| 9651543 |
Malaria antigen screening method |
Joseph T. Bruder, Duncan McVey, Douglas E. Brough, C. Richter King, Denise Louise Doolan +5 more |
2017-05-16 |
|
| 9561291 |
Methods of targeting T-cells to tumors |
Tibor Bakács, Miklos Szabo |
2017-02-07 |
|
| 8765146 |
Adenoviral vector-based malaria vaccines |
Joseph T. Bruder, C. Richter King, Duncan McVey, Damodar Ettyreddy, Denise Louise Doolan +1 more |
2014-07-01 |
$1,607,000 |
| 8450055 |
Malaria antigen screening method |
Joseph T. Bruder, Duncan McVey, Douglas E. Brough, C. Richter King, Denise Louise Doolan +5 more |
2013-05-28 |
|
| 8398969 |
Compositions and methods for the treatment of viral hepatitis |
Tibor Bakács, Vilmos Palya |
2013-03-19 |
|
| 7195896 |
Complementary adenoviral vector systems and cell lines |
Douglas E. Brough, Duncan McVey, Joseph T. Bruder, Alena Lizonova |
2007-03-27 |
$3,784,000 |
| 7141406 |
Efficient purification of adenovirus |
Miguel Carrion, Marilyn Menger |
2006-11-28 |
$1,142,000 |
| 7070930 |
Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
Duncan McVey, Douglas E. Brough, Mohammed Zuber |
2006-07-04 |
|
| 6998263 |
Methods of preparing and using a viral vector library |
Duncan McVey, Thomas Wickham, Joseph T. Bruder, Douglas E. Brough |
2006-02-14 |
$1,615,000 |
| 6951755 |
Vectors and methods for gene transfer |
Thomas Wickham, Douglas E. Brough |
2005-10-04 |
$2,382,000 |
| 6939540 |
Method of enhancing bone density |
Ronald G. Crystal, Chisa Hidaka, Oheneba Boachie-Adjei, Bernard A. Rawlins |
2005-09-06 |
$2,796,000 |
| 6913927 |
Non-adenoviral gene product-based complementing cells for adenoviral vectors |
Douglas E. Brough, Jason G. D. Gall |
2005-07-05 |
$1,756,000 |
| 6908762 |
Method of preparing a eukaryotic viral vector |
Duncan McVey |
2005-06-21 |
$1,819,000 |
| 6861229 |
Method of identifying a gene product |
Miguel Carrion |
2005-03-01 |
$1,843,000 |
| 6821775 |
Viral vector encoding pigment epithelium-derived factor |
Douglas E. Brough, Duncan McVey, Lisa Wei |
2004-11-23 |
$1,846,000 |
| 6756044 |
Antigenic complexes and methods |
Petrus W. Roelvink, Joseph T. Bruder, Thomas Wickham |
2004-06-29 |
$2,365,000 |
| 6753321 |
Method of modulating neovascularization |
— |
2004-06-22 |
$2,295,000 |
| 6740525 |
Adenoviral capsid containing chimeric protein IX |
Petrus W. Roelvink, Thomas Wickham |
2004-05-25 |
$2,640,000 |
| 6682929 |
Adenovector complementing cells |
Douglas E. Brough, Jason G. D. Gall |
2004-01-27 |
$5,331,000 |
| 6677156 |
Non-adenoviral gene product-based complementing cells for adenoviral vectors |
Douglas E. Brough, Jason G. D. Gall |
2004-01-13 |
$4,488,000 |
| 6660521 |
Use of trans-activation and CIS-activation to increase the persistence of a transgene in an at least E4-deficient adenovirus |
Douglas E. Brough |
2003-12-09 |
$4,871,000 |
| 6649373 |
Use of trans-activation and CIS-activation to modulate the persistence of expression of a transgene |
Douglas E. Brough |
2003-11-18 |
$2,876,000 |
| 6649407 |
Targeting adenovirus with use of constrained peptide motifs |
Thomas Wickham, Petrus W. Roelvink |
2003-11-18 |
$2,876,000 |
| 6596270 |
Methods of administering adenoviral vectors |
Joseph T. Bruder |
2003-07-22 |
$1,417,000 |
| 6586226 |
Efficient purification of adenovirus |
Miguel Carrion, Marilyn Menger |
2003-07-01 |
$1,425,000 |